The goal of this PREDICT is to assess a personalize approach to screening and management of cervical cancer testing. The investigators will evaluate patients who are due for a follow up cervical cancer screening in the primary care clinics in the Massachusetts General Brigham system. Patients will be randomized by clinic into three different arms (Arm 1: standard care, Arm 2: visit based reminders, Arm 3: visit based reminders and population health outreach)
have a cervix and are 21-70 years old
receive care at a participating primary care practice (i.e. PCP team visit within past 3 years)
have had a Pap and/ or HPV test within the past 3.5 years
has a CCSM result that suggest a 5-year risk of developing CIN3+ that warrants surveillance at 1 or 3 years, diagnostic colposcopy, or treatment (i.e., above average risk).
were diagnosed with cervical cancer/ CIN3+ prior to the most recent screening Pap or HPV test
have had their cervix removed
are not English or Spanish-speaking.